Hospital & Internal Medicine lectures are intended for the medical professional who enjoys learning for the sake of it.
Dr. Porat is a practicing Hospitalist and Board Certified in Internal Medicine.
Heart Failure with Preserved Ejection Fraction (Diastolic CHF) and SGLT-2 Inhibitor Therapy
The double-blind, randomized phase III EMPEROR-Preserved trial showed a benefit of the sodium-glucose cotransporter-2 (SGLT2) inhibitor empagliflozin in patients with heart failure with preserved ejection fraction (HFpEF).
Now let us dig a bit more into those headlines.
Should You Postpone Interventions for INFECTED Necrotizing Pancreatitis?
An important recently published randomized control trial provides guidance on this controversy.
Spontaneous Bacterial Peritonitis - Unique Infections in Cirrhosis part 2
Unique Infectious Considerations in Cirrhosis - part 1
Diabetic Gastric Emptying Abnormalities (and sometimes normal) - Part 1
Almost nobody feels comfortable managing DELAYED gastric emptying (gastroparesis) and very few medical providers even think about RAPID gastric emptying in their diabetic patients. Even if you send these patients to GI specialists, your blood sugar co-management of these patients can be heavily impacted by these issues. Is delayed gastric emptying always a bad thing? When your patient has upper GI symptoms, how often is it a gastric emptying abnormality? Time for some answers.
Gastric Emptying Abnormalities - Part 2
Can we trust a nuclear study to nail the diagnosis? Are motor abnormalities really the cause of symptoms? What is a POP procedure?
Just listened to the episode on ITP --- very informative and helpful. There should be more podcasts like this out there.